How is the 10x Genomics Inc - Ordinary Shares - Class A today?

The 10x Genomics Inc - Ordinary Shares - Class A today is trading in the green, up by 0.26% at 11.73.

How has 10x Genomics Inc - Ordinary Shares - Class A performed historically?

The 10x Genomics Inc - Ordinary Shares - Class A is currently trading up 0.26% on an intraday basis in the past week the index rose 8.51%. The index has been up 28.06% in the past quarter and fell -39.69% in the past year. You can view this in the overview section.

What is 10x Genomics Inc - Ordinary Shares - Class A Annual Revenue?

10x Genomics Inc - Ordinary Shares - Class A Annual Revenue fell 1.28%, in the last year to $610.78 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is 10x Genomics Inc - Ordinary Shares - Class A Annual Net Profit?

10x Genomics Inc - Ordinary Shares - Class A Annual Net Profit rose 28.41% in the last year to $182.63 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is 10x Genomics Inc - Ordinary Shares - Class A Price to Earning Ratio?

10x Genomics Inc - Ordinary Shares - Class A Price to Earning Ratio is -9.2, which is negative.

What is 10x Genomics Inc - Ordinary Shares - Class A Stock Price?

10x Genomics Inc - Ordinary Shares - Class A Stock Price fell 39.69% and underperformed its sector by 74.56% in the past year.

What is 10x Genomics Inc - Ordinary Shares - Class A Quarterly Revenue?

10x Genomics Inc - Ordinary Shares - Class A Quarterly Revenue rose 9.84% YoY to $154.88 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is 10x Genomics Inc - Ordinary Shares - Class A Quarterly Net profit?

10x Genomics Inc - Ordinary Shares - Class A Quarterly Net profit rose 42.69% YoY to $34.36 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is 10x Genomics Inc - Ordinary Shares - Class A Debt to Equity Ratio?

10x Genomics Inc - Ordinary Shares - Class A Debt to Equity Ratio of 0.12 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is 10x Genomics Inc - Ordinary Shares - Class A Return on Equity(ROE)?

10x Genomics Inc - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -25.17%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is 10x Genomics Inc - Ordinary Shares - Class A Mutual Fund Holding?

10x Genomics Inc - Ordinary Shares - Class A Mutual Fund Holding decreased by 5.18% in the last quarter to 57.12.

What is 10x Genomics Inc - Ordinary Shares - Class A Promoter Share Holding?

10x Genomics Inc - Ordinary Shares - Class A Promoter Share Holding decreased by 0.34% in the most recent quarter to 10.64%.

What is 10x Genomics Inc - Ordinary Shares - Class A Interest Coverage Ratio?

10x Genomics Inc - Ordinary Shares - Class A Interest Coverage Ratio is -44424, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is 10x Genomics Inc - Ordinary Shares - Class A Institutional Holding?

10x Genomics Inc - Ordinary Shares - Class A Institutional Holding remained the same in the last quarter at 96.65%.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
10X GENOMICS INC - ORDINARY SHARES - CLASS A

10x Genomics Inc - Ordinary Shares - Class A XNAS: TXG

10x Genomics Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: 10x Genomics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: 10x Genomics Inc - Ordinary Shares - Class A
Rating: 2.023361
Author: Trendlyne DVM scores

Expensive Performer

about

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and ...

11.73 0.03 (0.26%)

52.63% Fall from 52W High

17.9M

XNAS Volume

High volume today

XNAS 27 Jun, 2025 5:30 PM (EDT)

Medium Financial Strength

44.4 / 100

Expensive Valuation

21.0 / 100

Technically Neutral

52.0 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 12%

13 analysts

10x Genomics Inc - Ordinar... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

10x Genomics Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and ...

52.63% Fall from 52W High

High volume today

SWOT Analysis

10x Genomics Inc - Ordinar... Live Price Chart

10x Genomics Inc - Ordinary Shares - Class A FAQ

How is 10x Genomics Inc - Ordinary Shares - Class A today?

10x Genomics Inc - Ordinary Shares - Class A today is trading in the green, and is up by 0.26% at 11.73.

How has 10x Genomics Inc - Ordinary Shares - Class A performed historically?

10x Genomics Inc - Ordinary Shares - Class A is currently trading up 0.26% on an intraday basis. In the past week the stock rose 8.51%. stock has been up 28.06% in the past quarter and fell -39.69% in the past year. You can view this in the overview section.